Cargando…
Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484265/ https://www.ncbi.nlm.nih.gov/pubmed/36121173 http://dx.doi.org/10.1002/ctm2.895 |
| _version_ | 1784791845576900608 |
|---|---|
| author | Arnardottir, Hildur Pawelzik, Sven‐Christian Sarajlic, Philip Quaranta, Alessandro Kolmert, Johan Religa, Dorota Wheelock, Craig E. Bäck, Magnus |
| author_facet | Arnardottir, Hildur Pawelzik, Sven‐Christian Sarajlic, Philip Quaranta, Alessandro Kolmert, Johan Religa, Dorota Wheelock, Craig E. Bäck, Magnus |
| author_sort | Arnardottir, Hildur |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9484265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94842652022-09-29 Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial Arnardottir, Hildur Pawelzik, Sven‐Christian Sarajlic, Philip Quaranta, Alessandro Kolmert, Johan Religa, Dorota Wheelock, Craig E. Bäck, Magnus Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2022-09-19 /pmc/articles/PMC9484265/ /pubmed/36121173 http://dx.doi.org/10.1002/ctm2.895 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Arnardottir, Hildur Pawelzik, Sven‐Christian Sarajlic, Philip Quaranta, Alessandro Kolmert, Johan Religa, Dorota Wheelock, Craig E. Bäck, Magnus Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_full | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_fullStr | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_full_unstemmed | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_short | Immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for COVID‐19: A single‐blind randomized controlled trial |
| title_sort | immunomodulation by intravenous omega‐3 fatty acid treatment in older subjects hospitalized for covid‐19: a single‐blind randomized controlled trial |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484265/ https://www.ncbi.nlm.nih.gov/pubmed/36121173 http://dx.doi.org/10.1002/ctm2.895 |
| work_keys_str_mv | AT arnardottirhildur immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT pawelziksvenchristian immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT sarajlicphilip immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT quarantaalessandro immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT kolmertjohan immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT religadorota immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT wheelockcraige immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial AT backmagnus immunomodulationbyintravenousomega3fattyacidtreatmentinoldersubjectshospitalizedforcovid19asingleblindrandomizedcontrolledtrial |